{"id":"https://openalex.org/W2166094088","doi":"https://doi.org/10.2174/187152807783334300","title":"TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders","display_name":"TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders","alternate_titles":[],"publication_year":2007,"publication_date":"2007-12-01","ids":{"openalex":"https://openalex.org/W2166094088","doi":"https://doi.org/10.2174/187152807783334300","mag":"2166094088","pmid":"https://pubmed.ncbi.nlm.nih.gov/18220957"},"language":"en","primary_location":{"id":"doi:10.2174/187152807783334300","doi":"https://doi.org/10.2174/187152807783334300","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152807783334300","pdf_url":null,"source":{"id":"https://openalex.org/S2765056663","display_name":"Inflammation & Allergy - Drug Targets","issn_l":"1871-5281","issn":["1871-5281","2212-4055"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammation &amp; Allergy-Drug Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2166094088"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101723701","display_name":"Lars Karlsson","orcid":"https://orcid.org/0000-0002-8804-1899","observed_orcids":["https://orcid.org/0000-0002-8804-1899"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Karlsson","raw_affiliation_strings":["Department of Immunology, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111524553","display_name":"Siquan Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siquan Sun","raw_affiliation_strings":["Department of Immunology, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113525949","display_name":"Navin L. Rao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Navin Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026952377","display_name":"Jennifer D. Venable","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer Venable","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053042960","display_name":"Robin L. Thurmond","orcid":"https://orcid.org/0000-0001-6911-889X","observed_orcids":["https://orcid.org/0000-0001-6911-889X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robin Thurmond","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6345,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.90891464,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"6","issue":"4","first_page":"223","last_page":"235"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/toll-like-receptors","display_name":"Toll-like receptors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/immune-mediated-inflammatory-disorders","display_name":"immune-mediated inflammatory disorders","score":0.9300000071525574},{"id":"https://openalex.org/keywords/nucleic-acid-sensing","display_name":"nucleic acid sensing","score":0.6029999852180481},{"id":"https://openalex.org/keywords/imiquimod","display_name":"imiquimod","score":0.8109999895095825},{"id":"https://openalex.org/keywords/oligodeoxynucleotides","display_name":"oligodeoxynucleotides","score":0.9290000200271606},{"id":"https://openalex.org/keywords/chloroquine","display_name":"chloroquine","score":0.7739999890327454},{"id":"https://openalex.org/keywords/hydroxychloroquine","display_name":"hydroxychloroquine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/quinacrine","display_name":"quinacrine","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antimalarial-drugs","display_name":"antimalarial drugs","score":0.746999979019165},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9350000023841858},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/sjogren-s-syndrome","display_name":"Sj\u00f6gren's syndrome","score":0.9639999866485596},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.31200000643730164}],"concepts":[{"id":"https://openalex.org/C2779836521","wikidata":"https://www.wikidata.org/wiki/Q14914081","display_name":"TLR7","level":5,"score":0.6537706851959229},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5656464695930481},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5610557794570923},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.42413362860679626},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3952399492263794},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3018449544906616},{"id":"https://openalex.org/C2776709828","wikidata":"https://www.wikidata.org/wiki/Q408004","display_name":"Toll-like receptor","level":4,"score":0.16202327609062195},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.09714660048484802}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018448","descriptor_name":"Models, Immunological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051199","descriptor_name":"Toll-Like Receptor 7","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051199","descriptor_name":"Toll-Like Receptor 7","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051217","descriptor_name":"Toll-Like Receptor 9","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051217","descriptor_name":"Toll-Like Receptor 9","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/187152807783334300","doi":"https://doi.org/10.2174/187152807783334300","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152807783334300","pdf_url":null,"source":{"id":"https://openalex.org/S2765056663","display_name":"Inflammation & Allergy - Drug Targets","issn_l":"1871-5281","issn":["1871-5281","2212-4055"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammation &amp; Allergy-Drug Targets","raw_type":"journal-article"},{"id":"pmid:18220957","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18220957","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammation & allergy drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W193295172","https://openalex.org/W2618081269","https://openalex.org/W3010832552","https://openalex.org/W2005433020","https://openalex.org/W159385813","https://openalex.org/W4376105261","https://openalex.org/W4417231608","https://openalex.org/W4387032801","https://openalex.org/W2114403343","https://openalex.org/W2805170286"],"abstract_inverted_index":{"There":[0],"is":[1,27,120],"an":[2],"increasing":[3],"interest":[4],"in":[5,20,56,61,73,118,147,182,214,235],"ligands":[6],"of":[7,115,191,232,238],"nucleic":[8],"acid-sensing":[9],"Toll-like":[10],"receptors":[11],"(TLR),":[12],"especially":[13],"TLR7":[14,24,175],"and":[15,45,69,75,86,109,164,205,226],"TLR9,":[16],"for":[17,34,59,174,229],"pharmacological":[18],"intervention":[19],"various":[21],"diseases.":[22],"The":[23],"agonist":[25],"imiquimod":[26],"currently":[28,55],"used":[29,90],"as":[30,64,67,70,80,101,133,135,150,152,156,186],"a":[31,144,201,236],"topical":[32],"treatment":[33],"genital":[35],"warts":[36],"caused":[37],"by":[38],"human":[39],"papillomavirus":[40],"(HPV),":[41],"actinic":[42],"keratosis":[43],"(AK)":[44],"superficial":[46],"basal":[47],"cell":[48],"carcinoma.":[49],"Oligodeoxynucleotides":[50],"(ODN)":[51],"TLR9":[52],"agonists":[53],"are":[54],"clinical":[57,212],"trials":[58],"use":[60,114,190,231],"lung":[62],"cancer,":[63],"anti-viral":[65],"therapy,":[66],"adjuvants":[68],"immune":[71],"modulators":[72],"asthma":[74],"allergies.":[76],"TLR7/9":[77,142,198,224],"antagonists,":[78],"such":[79,100,155,185,233],"the":[81,92,113,124,148,189,227,230],"anti-malaria":[82],"drugs":[83],"chloroquine,":[84],"hydroxychloroquine":[85],"quinacrine,":[87],"have":[88,139,210],"been":[89],"since":[91],"1950s":[93],"to":[94,123,221],"treat":[95],"immune-mediated":[96],"inflammatory":[97,160],"disorders":[98],"(IMID)":[99],"rheumatoid":[102],"arthritis":[103],"(RA),":[104],"systemic":[105],"lupus":[106],"erythematosus":[107],"(SLE)":[108],"Sj\u00f6gren's":[110],"syndrome.":[111],"However,":[112],"these":[116,215],"anti-malarials":[117],"IMID":[119,154],"limited":[121],"due":[122],"side":[125],"effects":[126],"or":[127,194],"suboptimal":[128],"efficacy.":[129],"Pre-clinical":[130],"animal":[131],"models":[132],"well":[134,151],"genetic":[136],"linkage":[137],"studies":[138],"indicated":[140],"that":[141,170],"play":[143],"pivotal":[145],"role":[146],"aforementioned":[149],"other":[153],"multiple":[157],"sclerosis":[158],"(MS),":[159],"bowl":[161],"disease":[162],"(IBD)/colitis":[163],"psoriasis.":[165],"Recent":[166],"evidence":[167],"has":[168],"suggested":[169],"selective,":[171],"specific":[172],"antagonists":[173,225],"and/or":[176],"9":[177],"might":[178],"be":[179],"more":[180],"beneficial":[181],"certain":[183],"diseases,":[184],"SLE.":[187],"Thus,":[188],"suppressive":[192],"ODN":[193],"novel":[195,223],"small":[196],"molecule":[197],"inhibitors":[199],"with":[200],"larger":[202],"safety":[203],"window":[204],"differentiated":[206],"selectivity":[207],"may":[208],"potentially":[209],"significant":[211],"utility":[213],"IMID.":[216,239],"Herein,":[217],"we":[218],"review":[219],"efforts":[220],"develop":[222],"rationale":[228],"therapeutics":[234],"variety":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2166094088","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
